راهن٠ای جا٠ع تشخیص و در٠ان دیابت - دانشگاه علو٠پزشکی اردبیل

245پیشگیري یا بهتأخیر انداختن بروز دیابت نوع 21. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995–2025: preva-lence, numerical estimates,and projec-tions. Diabetes Care 21:1414–1431, 19982. Reaven GM: Banting Lecture: role of insu-lin resistance in human disease. Diabetes 37:1595–1607, 19883. DeFronzo RA, Ferrannini E: Insulin resis-tance: a multifaceted syndrome responsi-ble for NIDDM, obesity,hypertension, dyslipidemia, and atherosclerotic cardio-vascular disease. Diabetes Care 14:173–194, 19914. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, Holman RR: Risk factors forcoronary artery dis-ease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Di-abetesStudy (UKPDS 23). BMJ 316:823–828, 19985. The DECODE Study Group: Glucose tol-erance and cardiovascular mortality: comparison of fasting and 2-hour diag-nostic criteria. Arch Intern Med 161:397– 405, 20016. Eastman RC, Cowie CC, Harris MI: Undi-agnosed diabetes or impaired glucose tol-erance andcardiovascular risk. Diabetes Care 20:127–128, 19977. Saydah SH, Loria CM, Eberhardt MS, Brancati FL: Subclinical states of glucose intolerance and risk ofdeath in the U.S. Diabetes Care 24:447–453, 20018. Coutinho M, Gerstein HC, Wang Y, Yusuf S: The relationship between glucose and incident cardiovascularevents: a metar-egression analysis of published data from 20 studies of 95,783 individuals followed for 124years. Diabetes Care 22:233–240, 19999. Balkau B, Shipley M, Jarrett RJ, Pyorala K, Pyorala M, Forhan A, Eschwege E: High blood glucoseconcentration is a risk fac-tor for mortality in middle-aged nondia-betic men: 20-year follow-up in the WhitehallStudy, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21:360 –367, 199810. Bjornholt JV, Erikssen G, Aaser E, Sand-vik L, Nitter-Hauge S, Jervell J, Erikssen J, Thaulow E: Fastingblood glucose: an un-derestimated risk factor for cardiovascu-lar death: results from a 22-year follow-up ofhealthy nondiabetic men. Diabetes Care 22:45–49, 199911. Harris MI: Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 16: 642–652, 199312. Wei M, Gaskill SP, Haffner SM, Stern MP: Effects of diabetes and level of glycemia on all-cause andcardiovascular mortality: the San Antonio Heart Study. Diabetes Care 21:1167–1172, 199813. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascularmorbidity and mortal-ity associated with the metabolic syn-drome. Diabetes Care 24:683–689, 200114. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Mortality from coronary heart disease and stroke inrelation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) 287:867–870, 198315. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas orinsulin compared with conventional treatment and risk of complications in patients with type 2 di-abetes(UKPDS 33). Lancet 352:837–853, 199816. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metforminon complications in overweight patients with type 2 diabe-tes (UKPDS 34). Lancet 352:854–865, 199817. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M:Intensive insulin therapy prevents the progression of dia-betic microvascular complications in Jap-anesepatients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes ResClin Pract 28:103–117, 199518. Reichard P, Nilsson BY, Rosenqvist U: The effect of long-term intensified insulin treatment on thedevelopment of microvascular complications of diabetes mellitus. N Engl J Med 329:304–309, 199319. Moss SE, Klein R, Klein BE, Meuer SM: The association of glycemia and cause-specific mortality in adiabetic population. Arch Intern Med 154:2473–2479, 199420. Khaw KT, Wareham N, Luben R, Bing-ham S, Oakes S, Welch A, Day N: Gly-cated haemoglobin,diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer andnutrition (EPIC-Norfolk) BMJ 322:15– 18, 200121. The Diabetes Control and Complications Trial Research Group: The effect of inten-sive treatment ofdiabetes on the develop-ment and progression of long-term complications in insulin-dependent dia-betesmellitus. NEngl J Med 329:977–986, 199322. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR:Association of glycaemia with macrovascular and micro-vascular complications of type 2 diabetes (UKPDS35): prospective observational study. BMJ 321:405–412, 2000